Post-COVID-19 Syndrome Clinical Trial
Official title:
Impact Of Sensory Re-Education Paradigm On Sensation And Quality Of Life In Patients Post-Covid 19 Polyneuropathy
This study will be conducted to investigate the effect of a sensory re-education paradigm on sensation and proprioception in patients with post covid-19 neuropathy.
The Coronavirus disease has profoundly impacted the world, altering the functioning of the population and health system. it is so far affected more than 532 million cases and 6.3 million confirmed deaths (WHO., 2020). Recent studies documented that COVID-19-associated peripheral neuropathy is a common and frequent problem, with neuro-muscular complications. This phenomenon is widespread in those with comorbidities, such as diabetes mellitus, which may result from immune processes or as side effects of some medications used to manage COVID-19 symptoms, such as hydroxychloroquine, clindamycin, and steroids. To a lesser extent, prolonged hospitalization may cause entrapment neuropathy (peripheral nerve compression). Most physiotherapists focus on motor improvements rather than sensibility improvements though the sensory system may have the upper hand in improving motor function. Therefore; the sensory re-education paradigm should be assessed in randomized trials with a blinded assessment of functional outcomes to evaluate its effectiveness in patients with post covid-19 neuropathic patients. Currently, there is not enough research addressing the impact of the sensory re-education paradigm on sensation and quality of life in neuropathic patients post-covid19. forty patients will be assigned randomly into two equal groups; the study group will receive sensory re-education paradigm and traditional treatment while the control group will receive traditional treatment only. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06073002 -
Effects of a Home-Based Exercise Intervention in Subjects With Long COVID
|
N/A | |
Completed |
NCT05047952 -
Vortioxetine for Post-COVID-19 Condition
|
Phase 2 | |
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Recruiting |
NCT06091384 -
Inspiratory Muscle Strength Training in Post-Covid Syndrome
|
N/A | |
Not yet recruiting |
NCT06267300 -
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
|
Phase 3 | |
Recruiting |
NCT05986422 -
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
|
Phase 2 | |
Not yet recruiting |
NCT05534997 -
Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT05638633 -
Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT05630040 -
VNS for Long-COVID-19
|
N/A | |
Recruiting |
NCT05841498 -
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
|
N/A | |
Enrolling by invitation |
NCT05981872 -
EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19
|
N/A | |
Active, not recruiting |
NCT05543408 -
Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"
|
N/A | |
Recruiting |
NCT05817032 -
Effect of Telerehabilitation Practice in Long COVID-19 Patients
|
N/A | |
Recruiting |
NCT05823896 -
imPROving Quality of LIFe In the Long COVID Patient
|
Phase 2 | |
Completed |
NCT05764070 -
Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients
|
N/A | |
Completed |
NCT05765591 -
Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome
|
N/A | |
Recruiting |
NCT05918965 -
Vagus Stimulation in Female Long COVID Patients.
|
N/A | |
Not yet recruiting |
NCT06231238 -
Balance Acceptance and Commitment Therapy for Long COVID
|
Phase 2 | |
Completed |
NCT06282627 -
The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
|
||
Completed |
NCT05648734 -
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
|